PA

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lewiecki EM - Denosumab is a promising therapeutic agent for the management of postmenopausal osteoporosis and rheumatoid arthritis.

Related Articles

Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
The Journal of Urology, 11/16/09    Relevance Score: 87%

A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09    Relevance Score: 83%

Bone health and prostate cancer
Prostate Cancer & Prostatic Diseases, 11/13/09    Relevance Score: 77%

Today in Women`s Health...keeping you current

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
International Journal of Women's Health, 12/18/09

Influence of sex hormones and phytoestrogens on heart disease in men and women
Women's Health, 12/18/09

Nipple discharge screening
Women's Health, 12/18/09